Hepatocyte Growth Factor/c-Met Signaling in Regulating Urokinase Plasminogen Activator in Human Stomach Cancer: A Potential Therapeutic Target for Human Stomach Cancer

Background Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various types of cancers. However, the mechanisms by which HGF/c-Met signaling mediates cancer progression and metastasis are unclear. Methods We investigated the roles of HGF/c-Met in tumor progression and metastasis in NUGC-3 and MKN-28 stomach cancer cell lines. Results Treatment with HGF increased c-Met phosphorylation in a dose-dependent manner, as well as increasing cell proliferation. HGF treatment also increased the protein level and the activity of uPA in NUGC-3 and MKN-28 cells. A monoclonal antibody against human uPA receptor (uPAR), mAb 3936, inhibited HGF-mediated tumor cell invasion in a dose-dependent manner. Down-regulation of uPA using uPA-shRNA induced a decrease in in vitro cell invasion in NUGC-3 cells. Conclusions These results suggest that NUGC-3 and MKN-28 cells express functional c-Met, which may provide a therapeutic target for interfering with metastases of cancer cells by inhibiting uPA and uPAR-mediated proteolysis.

[1]  G. Markus,et al.  Secretion of plasminogen activators by human colorectal and gastric tumor explants , 1988, Clinical & Experimental Metastasis.

[2]  H. Kim,et al.  Relationship between Urokinase-Type Plasminogen Receptor, Interleukin-8 Gene Expression and Clinicopathological Features in Gastric Cancer , 2004, Oncology.

[3]  Kyung-Hee Lee,et al.  Invasion-Metastasis by Hepatocyte Growth Factor/c-Met Signaling Concomitant with Induction of Urokinase Plasminogen Activator in Human Pancreatic Cancer: Role as Therapeutic Target. , 2003, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  V. Dessirier,et al.  Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. , 2001, Carcinogenesis.

[5]  N. Shinomiya,et al.  Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines. , 2000, International journal of oncology.

[6]  Peter Gierschik,et al.  Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration , 2000, Oncogene.

[7]  H. Friess,et al.  Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. , 1997, British Journal of Cancer.

[8]  G. V. Vande Woude,et al.  Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. , 1996, Oncogene.

[9]  G. V. Vande Woude,et al.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network , 1996, Molecular and cellular biology.

[10]  T. Nakamura,et al.  Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection. , 1995, Cancer letters.

[11]  H. Allgayer,et al.  Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. M. Mueller,et al.  Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. , 1994, Cancer research.

[13]  T. Nakamura,et al.  Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. , 1994, Oncogene.

[14]  J. Rubin,et al.  Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. , 1993, Biochimica et biophysica acta.

[15]  F. Ali-Osman,et al.  Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. , 1993, Cancer research.

[16]  D. Boyd,et al.  Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. , 1991, Cancer research.

[17]  P. Comoglio,et al.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.

[18]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[19]  L. Kirkeby,et al.  Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. , 1991, The American journal of pathology.

[20]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[21]  G. V. Vande Woude,et al.  Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  R. Medcalf,et al.  Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion , 1989, The Journal of cell biology.

[23]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[24]  P. Comoglio,et al.  p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line , 1988, Molecular and cellular biology.

[25]  E. Appella,et al.  Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. , 1988, Cancer research.

[26]  Toshikazu Nakamura,et al.  Purification and subunit structure of hepatocyte growth factor from rat platelets , 1987, FEBS letters.

[27]  D. Belin,et al.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. , 1987, Cancer research.

[28]  T. Suyama,et al.  Primary structure of single-chain pro-urokinase. , 1985, The Journal of biological chemistry.

[29]  A. Corti,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[31]  S. Kohga,et al.  Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. , 1983, Cancer research.

[32]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[33]  G. Markus,et al.  Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. , 1980, Cancer research.